🔗 Visit the ClinicalTrials.gov page for NCT01729806
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. | J Leukoc Biol | 2013 | 1.90 |
2 | Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. | Oncoimmunology | 2014 | 1.22 |
3 | Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". | Toxins (Basel) | 2014 | 0.92 |
4 | The past, present and future of immunotherapy against tumor. | Transl Lung Cancer Res | 2015 | 0.85 |
5 | Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy. | Pharmaceuticals (Basel) | 2015 | 0.78 |
6 | Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet? | Bone Marrow Transplant | 2015 | 0.77 |